The CFAR Developmental Core is the largest component of the DM ASS CFAR. The Developmental Core directly supports AIDS Research at the institution by funding projects in the following categories: ? Funding for projects from junior and unfunded investigators as well as new recruits in order to accelerate establishment of their research programs. ? Funding for translational research projects between basic and clinical investigators and interdisciplinary projects that harness the expertise of investigators in other research fields. ? Funding for innovative and high-risk projects that target significant research issues in the AIDS field. Applications for developmental funds will be solicited through an annual request for proposals (RFP) that is advertised on the CFAR website and electronically circulated around all departments and programs at UMASS. Unbiased and comprehensive peer review of developmental applications will be the responsibility of the UMASS CFAR Internal Advisory Board. Applications will be prioritized on the basis of scientific merit, relevance to AIDS and the ability to impact the research program of a junior investigator. The value of a CFAR award will be expanded through access to CFAR Core facilities. Mentoring of unsuccessful developmental grant applicants will increase the competitiveness of the application in the next cycle of developmental grant applications. In the previous funding period, the Developmental Core has allocated support for 5-6 developmental grants each year. A broad spectrum of research activities from basic and clinical research to drug discovery has received developmental support. The majority of CFAR awards have been made to junior investigators and new CFAR recruits. The extent to which developmental funds have leveraged extramural funding has been very significant. 1.1 million dollars have been used to fund 41 new investigator, interdisciplinary and innovative research projects (new and competing applications) that were selected from over 80 applications and this has led to leveraging $15,379,000 dollars in extramural funding. The UMASS CFAR Directors believe that the support of junior investigators and of innovative, basic and translational science is one of the most important missions of the CFAR. This view is strongly endorsed by members of the internal and external advisory boards. In the next funding period, the Developmental Core will remain the largest component of the CFAR. In excess of 25% of CFAR funds will be allocated to the Developmental Core in [Order to support innovative and potentially high impact AIDS research.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Center Core Grants (P30)
Project #
5P30AI042845-12
Application #
7927079
Study Section
Special Emphasis Panel (ZAI1)
Project Start
Project End
Budget Start
2009-07-01
Budget End
2010-06-30
Support Year
12
Fiscal Year
2009
Total Cost
$366,163
Indirect Cost
Name
University of Massachusetts Medical School Worcester
Department
Type
DUNS #
603847393
City
Worcester
State
MA
Country
United States
Zip Code
01655
Gonzalez-Perez, Maria Paz; Peters, Paul J; O'Connell, Olivia et al. (2017) Identification of Emerging Macrophage-Tropic HIV-1 R5 Variants in Brain Tissue of AIDS Patients without Severe Neurological Complications. J Virol 91:
Ambade, Aditya; Satishchandran, Abhishek; Szabo, Gyongyi (2016) Alcoholic hepatitis accelerates early hepatobiliary cancer by increasing stemness and miR-122-mediated HIF-1? activation. Sci Rep 6:21340
Peters, Paul J; Gonzalez-Perez, Maria Paz; Musich, Thomas et al. (2015) Infection of ectocervical tissue and universal targeting of T-cells mediated by primary non-macrophage-tropic and highly macrophage-tropic HIV-1 R5 envelopes. Retrovirology 12:48
Fouda, Genevieve G; Cunningham, Coleen K; McFarland, Elizabeth J et al. (2015) Infant HIV type 1 gp120 vaccination elicits robust and durable anti-V1V2 immunoglobulin G responses and only rare envelope-specific immunoglobulin A responses. J Infect Dis 211:508-17
Musich, Thomas; O'Connell, Olivia; Gonzalez-Perez, Maria Paz et al. (2015) HIV-1 non-macrophage-tropic R5 envelope glycoproteins are not more tropic for entry into primary CD4+ T-cells than envelopes highly adapted for macrophages. Retrovirology 12:25
Gibson, Laura; Barysauskas, Constance M; McManus, Margaret et al. (2015) Reduced frequencies of polyfunctional CMV-specific T cell responses in infants with congenital CMV infection. J Clin Immunol 35:289-301
Greenough, Thomas C; Straubhaar, Juerg R; Kamga, Larisa et al. (2015) A Gene Expression Signature That Correlates with CD8+ T Cell Expansion in Acute EBV Infection. J Immunol 195:4185-97
Brehm, Michael A; Wiles, Michael V; Greiner, Dale L et al. (2014) Generation of improved humanized mouse models for human infectious diseases. J Immunol Methods 410:3-17
Luzuriaga, Katherine; Tabak, Barbara; Garber, Manuel et al. (2014) HIV type 1 (HIV-1) proviral reservoirs decay continuously under sustained virologic control in HIV-1-infected children who received early treatment. J Infect Dis 210:1529-38
Usami, Yoshiko; Göttlinger, Heinrich (2013) HIV-1 Nef responsiveness is determined by Env variable regions involved in trimer association and correlates with neutralization sensitivity. Cell Rep 5:802-12

Showing the most recent 10 out of 122 publications